SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Quantech
Quantech Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Quantech Spółka z Ograniczoną Odpowiedzialnością
Quantech Spółka z Ograniczoną Odpowiedzialnością (KRS 0000638534, NIP 1182129940) is a Polish company, headquartered in Izabelin B, Mazowieckie voivodeship. QUANTECH operates in: Other research and experimental development on natural sciences and engineering (PKD 72.19.Z). Industry: Research and development. The company has been listed in the National Court Register since September 23, 2016. QUANTECH's most recently reported net revenue was 0 PLN for 2020. QUANTECH's operations are currently suspended.
The company is currently suspended
Suspended since December 1, 2025
Negative equity
Negative equity in 2 of 2 available reporting years.
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
72.19.ZOther research and experimental development on natural sciences and engineering
Other activities
Credibility rating
5 / 100
Very poor credibility
Insolvency risk
suspended
Significant formal threat
Closure risk
80
/ 100
Extremely high risk
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/10 yrs
Board changes
1
1/10 yrs
PKD changes
0
0/10 yrs
Name changes
0
0/10 yrs
Data from 10 years of registry activity.
Payment reliability score from 2018–2020
Current: S (5/100)
Trend: stable (0.0 pts/year)
Spółka jest obecnie zawieszona – działalność operacyjna wstrzymana, wskaźnik wiarygodności odzwierciedla stan przed zawieszeniem.
Standard limit from 2018–2020
Current: 0 PLN
Safe: 0 PLN
Founded
September 23, 2016
9 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
IZABELIN B
MAZOWIECKIE
Primary PKD
72.19.Z
Other research and experimental development on natural sciences and…
Share capital
5.0 K PLN
100 shares total
Shareholders
3
shareholders
Board
1 person
Filed years
2 years
2018–2020 · profitable: 0/2
Registry entries
16
latest: December 10, 2025
Risk signals
Revenue
0 PLN
2020
Net profit
-437 PLN
2020
Assets
13.2 K PLN
2020
Equity
-66.8 K PLN
2020
Valuation
0 PLN
suspended
Rate business credibility - Quantech.
No ratings

News
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.

News
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
QUANTECH's board has 1 member.
16 historical registry entries for Quantech
Change in Section 6 (liquidation, bankruptcy or dissolution)
WA.XIV NS-REJ.KRS/17479/18/789
Filing documents submitted (2 documents)
Commercial proxy change, Shareholder change
WA.XIV NS-REJ.KRS/27282/21/88
Address change, Board change
WA.XIV NS-REJ.KRS/24139/22/979
Change in Section 6 (liquidation, bankruptcy or dissolution)
WZNOW/6211/25/367
Change in Section 6 (liquidation, bankruptcy or dissolution)
WA.XIV NS-REJ.KRS/63746/25/669
Latest reporting year
2020
Available years
4
Filing entries
0
Competing companies or those operating in the same market segment as Quantech (in Izabelin B, industry: Research and development).
WARSZAWA· Research and development
Revenue 2024: 2.9 B PLN
WARSZAWA· Research and development
Revenue 2024: 796.1 M PLN
WARSZAWA· Research and development
Revenue 2023: 609.6 M PLN
WARSZAWA· Research and development
Revenue 2024: 579.9 M PLN
WARSZAWA· Research and development
Revenue 2024: 499.5 M PLN
WARSZAWA· Research and development
Revenue 2024: 390.5 M PLN